Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics Previous close 79.36
Open 0.00
Day range 0.00 79.36
52-week range 0.00 89.01
Off day high 0.00%
Off 52-week high −10.84%
Volume 0.00
Avg. volume (3M) 3.13K
Market cap 643.67B
EPS (TTM) 2.84
Forward P/E —
P/E ratio (TTM) 27.94
Dividend yield —
Beta (5Y) —
Shares outstanding 8.11B
Short interest —
Earnings date Jul 30, 2025
Analyst target —
Profit margin —
No recent coverage in the 4Search index.
From articles in the 4Search news index.
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.
From Wikipedia , CC BY-SA 4.0
Earnings
Next report: Wed, Jul 30, 2025
Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).
Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).
Not eligible for Growth tech (U.S. technology stocks only).
Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).
A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.
Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use .